PLASTIPHARM
ActiveSummary
PLASTIPHARM is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show negative equity (-€54,474) and a net result of -€66,779. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 6,640 sector peers (NACE 64, financial year 2025). The company has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
03-02
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 3 days late
2025
30-01
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
31-01
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
31-01
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
31-01
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
30-06
Financial
Weakest financial yearnet -€2.4m
Net result drops to -€2.4m, the lowest in the series; recovery starts the following year.
27-01
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
31-01
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
2019
31-01
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
2018
30-01
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2017
19-01
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 23 annual accounts filed, the latest 10 are here; all 23 are under Financials.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.